APRIL BENTLEY: Open Payments
NPI 1174982029 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,000 in 100 payments from 21 companies in 2025. Trend: 2023 $2,449 · 2024 $1,794 · 2025 $2,000
Food & beverage: $1,901Education: $99
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $319 |
| ABBVIE INC. | 22 | $301 |
| Lundbeck LLC | 10 | $216 |
| Lilly USA, LLC | 7 | $135 |
| PFIZER INC. | 6 | $125 |
| Astellas Pharma US Inc | 2 | $120 |
| Novo Nordisk Inc | 6 | $114 |
| Orexo US, Inc. | 6 | $113 |
| Exact Sciences Corporation | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
Products named: Sunosi, VRAYLAR, Auvelity, VYEPTI, Zubsolv, NURTEC ODT, MOUNJARO, Kerendia.
Industry payments across MD — which companies pay providers there.
